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Abstract
Inflammation culminating in fibrosis contributes to progressive kidney disease. Crosstalk between 
the tubular epithelium and interstitial cells regulates inflammation by a coordinated release of 
cytokines and chemokines. Here we studied the role of heme oxygenase-1 (HO-1) and the heavy 
subunit of ferritin (FtH) in macrophage polarization and renal inflammation. Deficiency in HO-1 
was associated with increased FtH expression, accumulation of macrophages with a dysregulated 
polarization profile, and increased fibrosis following unilateral ureteral obstruction in mice; a 
model of renal inflammation and fibrosis. Macrophage polarization in vitro was predominantly 
dependent on FtH expression in isolated bone marrow-derived mouse monocytes. Utilizing 
transgenic mice with conditional deletion of FtH in the proximal tubules (FtHPT−/−) or myeloid 
cells (FtHLysM−/−), we found that myeloid FtH deficiency did not affect polarization or 
accumulation of macrophages in the injured kidney compared to wild-type (FtH+/+) controls. 
However, tubular FtH deletion led to a marked increase in pro-inflammatory macrophages. 
Furthermore, injured kidneys from FtHPT−/− mice expressed significantly higher levels of 
inflammatory chemokines and fibrosis compared to kidneys from FtH+/+ and FtHLysM−/− mice. 
Thus, there are differential effects of FtH in macrophages and epithelial cells, which underscores 
the critical role of FtH in tubular-macrophage crosstalk during kidney injury.
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Introduction
The kidney is a complex organ that is involved in a myriad of vital processes, which is made 
possible by a well-orchestrated milieu of different cell types. Damage to the kidney 
parenchyma leading to loss of kidney function results in significantly increased morbidity 
and mortality. In addition, infiltration of inflammatory cells at early stages in the injured 
kidneys, followed by tubulointerstitial fibrosis are common pathologic features of acute 
injury-mediated progressive kidney disease (1–3). The pathogenesis of progressive kidney 
disease is remarkably complex and includes activation of multiple pathways involved in 
inflammation and oxidative stress (4–7). Following injury, a cascade of events is initiated 
that leads to tubular epithelial injury and activation of tissue-resident and infiltrating 
macrophages. This cascade is the result of a coordinated action of cytokines/chemokines and 
reactive oxygen species. Furthermore, a single insult to the kidney also heightens the risk for 
the development of chronic kidney disease (CKD) (6,8,9).
Recent seminal work in this field has demonstrated that two distinct responses ensue 
following injury. First, the injured tubular epithelium triggers a robust local response by 
inducing several survival and regenerative pathways including upregulation of anti-oxidants 
and recruitment of inflammatory cells through release of chemokines and cytokines (6,10–
15). Of the anti-oxidants, we and others have demonstrated a protective role for the 
expression of heme oxygenase-1 (HO-1) and the heavy subunit of ferritin (FtH) during acute 
kidney injury (16–22). HO-1 catalyzes the breakdown of heme to carbon monoxide, bile 
pigments and ferrous iron. The iron released from this reaction is converted to a ferric form 
by FtH and securely stored in the ferritin shell thereby limiting iron-mediated oxidative 
stress (23). In addition to the oxidative changes within the tubular epithelium, proximal 
tubular cells also increase their production and secretion of chemokines that recruit and 
activate inflammatory cells (14,24–26).
The influx of these inflammatory cells, predominantly macrophages, comprise the second 
response to injury. Macrophages progressively accumulate in the injured kidney in response 
to chemokines and cytokines such as monocyte chemoattractant protein 1 (MCP-1), colony 
stimulating factor 1 (CSF-1) and Interleukin 6 (IL-6) and play a central role in propagation 
or resolution of injury (15,27–30). Early studies demonstrated that macrophage infiltration 
correlates with the severity of kidney injury in humans and animals, suggesting a pathogenic 
role for these cells (31–33). In fact, animal studies concluded that depletion of macrophages 
prior to injury led to amelioration of renal fibrosis while adoptive transfer of macrophages 
aggravated the injurious response (34–37). However, recent evidence suggests that while 
macrophage depletion in the early stages following injury is protective, depletion of 
macrophages during the resolution phase of injury delays recovery (24,38,39). This 
apparently contradictory role for macrophages can be explained by their heterogeneity for 
the expression of different proteins that enable cytotoxic or cytoprotective functions (40–
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43). This differential expression pattern allows for macrophages to be classified into two 
subclasses with polar functions: termed classically activated M1 and alternatively activated 
M2. M1 macrophages are characterized by the expression of high levels of pro-
inflammatory cytokines and increased production of reactive oxygen and nitrogen species. 
M2 macrophages are anti-inflammatory and produce metabolic intermediates such as 
ornithine and polyamines that enable tissue remodeling and homeostasis (41,44). In this 
context, HO-1 is robustly expressed by M2 macrophages, conferring potent anti-
inflammatory properties (45–48). This dichotomous polarization of macrophages 
underscores their diverse roles in regulating tissue injury and repair, providing exciting 
avenues to potentially modulate responses following injury.
Injury to the kidney parenchyma and inflammation are interdependent and form a vicious 
cycle where tubular injury facilitates macrophage influx and vice versa. This often 
perpetuates the development of fibrosis, an adverse complication compromising kidney 
function. It is therefore increasingly evident that dissecting the signaling mechanisms during 
cross-talk between parenchymal tubular cells and inflammatory cells is crucial for 
development of novel therapeutic interventions. We addressed the hypothesis that 
expression of HO-1 and FtH in proximal tubular epithelial cells and macrophages are 
involved in the mechanisms leading to exacerbation or resolution of inflammation-mediated 
fibrosis. To test this hypothesis, we utilized a well-established unilateral ureteral obstruction 
model (UUO), characterized by oxidative stress and inflammatory-mediated fibrosis, in 
order to elucidate the relative contribution of macrophages versus the kidney 
microenvironment in resolution of injury. We used transgenic mice with global deletion of 
HO-1 or conditional deletion of FtH in renal proximal tubules and/or myeloid cells, two 
cytoprotective anti-oxidant proteins that influence recovery and resolution following renal 
injury. While the mechanisms of injury and repair were determined using UUO as a model, 
the results from these studies may be applicable to inflammatory diseases where oxidative 
stress and inflammation play a determinant pathogenic role.
Results
HO-1 deficiency leads to increased inflammation following unilateral ureteral obstruction
In order to characterize the differential accumulation of immune cells following injury, cells 
were isolated from the contralateral and obstructed kidneys and analyzed by flow cytometry 
(Figure 1A). In agreement with previous reports (49), we first demonstrated that two 
populations of immune cells (CD45+) reside in the uninjured (contralateral) kidney (Figure 
1). The predominant population, which has been defined as dendritic cells, is phenotypically 
characterized as F4/80hiCD11blo while a second smaller population, defined as 
macrophages, is characterized as F4/80loCD11bhi phenotype. As previously reported in a 
model of AKI induced by ischemia-reperfusion injury (49), we demonstrated a specific and 
significant increase in the macrophage (CD11bhiF4/80lo) population after UUO, compared 
to the contralateral kidney (CD11bhighF4/80lo; 19.27±5.5% versus 4.80±0.65%) (Figure 1, 
supplemental figure 1). However, we observed a reduced proportion of dendritic cells 
(CD11bloF4/80high; 18.34±4.09% versus 49.8±10.3%) in the obstructed kidneys when 
compared to contralateral kidneys (Figure 1, supplemental figure 1). In addition, 
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granulocytes (neutrophils) were identified and excluded from the analysis based on their 
expression of Ly6C and GR-1. Intra-renal macrophages were further characterized based on 
Ly6C and CD11c expression (Figure 1B). Ly6C is a surface marker expressed by a subset of 
circulating monocytes that expand in the context of inflammation and then traffic to the site 
of injury (50,51). It is also expressed on pro-inflammatory M1 macrophages in the kidney 
and the heart (49,52). We found an increased proportion of Ly6C+ macrophages in kidneys 
subjected to UUO compared to contralateral kidneys (Figure 1B). In addition, we found that 
the Ly6C− macrophages exhibit a distinct CD11c+ phenotype, which is characteristic of the 
tissue-resident or tissue-reparative M2 macrophages (53,54).
We have previously demonstrated that HO-1−/− mice demonstrate significantly higher levels 
of F4/80+ cells and fibrosis following UUO compared to wild-type mice (55). Upon further 
characterization of the F4/80+ cells, we found that global HO-1 deficiency was associated 
with increased number of macrophages and dendritic cells in the injured kidneys (Figure 
1C). Of these macrophages, there was an increase in the number of Ly6C+CD11C+ 
macrophages (Figure 1C, Supplemental Figure 1A–B). Of note, the contralateral kidneys of 
HO-1−/− mice also demonstrated a significant increase in the accumulation of macrophages 
and dendritic cells (Supplemental Figure 1A–C).
We identified the phenotype of macrophages in the injured kidneys of HO-1−/− and HO-1+/+ 
mice after UUO. Consistent with previous reports, macrophages isolated from the injured 
kidneys of HO-1+/+ mice demonstrated a time-dependent phenotypic expression profile. 
These macrophages were predominantly M1 (iNOS, TNFα) at 2 days following injury 
whereas they expressed M2 marker (mannose receptor) at 7 days post injury (Figure 1D). 
However, HO-1+/+ macrophages isolated at different timepoints after injury did not 
demonstrate a significant change in arginase expression. On the contrary, the HO-1−/− 
macrophages exhibited a dysregulated expression profile with decreased expression of M1 
markers on day 2 and increased expression of M2 markers on day 2 and day 5. At day 7, 
mannose receptor, an M2 marker was markedly elevated in both HO-1+/+ and HO-1−/− mice 
kidneys, but was significantly lower in HO-1−/− kidneys (Figure 1D).
Heavy chain ferritin regulates macrophage polarization in vitro
In order to further investigate the dysregulated polarization in HO-1−/− macrophages, we 
isolated bone marrow derived monocytes of HO-1+/+ and HO-1−/− mice and polarized them 
to M1 or M2 macrophages in vitro using IFNγ or IL-4, respectively (Figure 2A). 
Corroborating our in vivo data, HO-1 deficient macrophages demonstrated increased 
propensity to polarize (increased iNOS and arginase expression) when compared to 
stimulated HO-1+/+ macrophages (Figure 2B, supplemental figure 2A). Interestingly, HO-1 
deficient macrophages demonstrated higher levels of FtH (Figure 2B). To determine 
whether FtH was responsible for increased polarization, we pre-treated HO-1−/− 
macrophages with deferoxamine, an iron chelator, to decrease FtH expression. Inhibition of 
FtH in the HO-1−/− macrophages reduced iNOS and arginase expression following 
stimulation with cytokines (Figure 2C, supplemental figure 2B). In order to verify that 
polarization was dependent on FtH and not iron, we pre-treated HO-1+/+ macrophages with 
apoferritin (ferritin shell made up of heavy and light subunits but devoid of iron) to increase 
Bolisetty et al. Page 4
Kidney Int. Author manuscript; available in PMC 2016 January 01.
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
FtH expression. In the presence of apoferritin, HO-1+/+ macrophages responded to cytokines 
with a significantly increased expression of iNOS and arginase and confirmed the 
contributory role of FtH in increasing the polarizability of macrophages (Figure 2D, 
supplemental figure 2C). This was also verified using recombinant FtH (Figure 2E, 
supplemental figure 2D). Furthermore, mutant FtH that is devoid of ferroxidase activity was 
also able to induce macrophage polarization, confirming that this process is independent of 
iron regulation by FtH (Figure 2E). Apoferritin and mutant ferritin also induced expression 
of HO-1 (Figure 2D–E). Of note, supplementation of by-products of the heme oxygenase 
reaction (carbon monoxide, biliverdin and bilirubin) also led to decreased expression of FtH 
and polarizability of HO-1 deficient macrophages (Supplemental Figure 3A). In addition, 
HO-1 overexpressing macrophages (isolated from humanized BAC transgenic mice 
expressing HO-1) demonstrated decreased expression of FtH and macrophage polarization 
markers, an effect that was reversed in the presence of apoferritin (Supplemental Figure 3B).
Myeloid-specific FtH deletion does not alter macrophage polarization following injury in 
vivo
Given the significance of FtH to mediate macrophage polarization, we hypothesized that 
deletion of FtH in myeloid cells, including macrophages, would significantly inhibit their 
polarization in vivo following UUO and thereby reduce inflammation. Of note, global FtH 
deficiency leads to embryonic lethality and hence we chose to generate targeted FtH deletion 
mice (56). To this end, we generated mice with myeloid-specific deletion of FtH 
(FtHLysM−/−) by breeding FtHlox/lox mice with LysM-Cre mice. Mice with myeloid-
restricted FtH deficiency (FtHLysM−/−) were born at the expected Mendelian ratio, were 
viable and fertile, and following six months of observation did not manifest any apparent 
abnormalities. FtHlox/lox mice were homozygous for the floxed allele and express FtH in 
macrophages and henceforth will be referred to as FtH+/+ mice. Deletion of FtH expression 
in macrophages of FtHLysM−/− mice was confirmed by mRNA and protein expression 
analysis on bone-marrow derived macrophages (Figure 3A–B). In addition, in vitro 
macrophage polarization was diminished in the absence of FtH in macrophages (Figure 3C). 
Interestingly, levels of the light chain of ferritin (FtL) and HO-1 were higher in FtHLysM−/− 
macrophages (Figure 3C).
In order to determine the significance of FtH deletion in macrophages during injury, we 
performed UUO on FtH+/+ and FtHLysM−/− mice and analyzed renal inflammation two days 
following injury (Figure 3D). The total number of macrophages and dendritic cells were not 
different in the FtHLysM−/− kidneys when compared to FtH+/+ kidneys (Figure 3E, 
Supplemental Figure 4). In addition, there was no significant difference in the number of 
Ly6C+CD11C+ and Ly6C+CD11clo macrophages in the myeloid-specific FtH deleted 
kidneys compared to FtH+/+ obstructed kidneys. Furthermore, circulating lymphocytes 
recruited to the kidney (CD62L+) at two days post-injury were not different between the two 
groups (Figure 3E). These results suggest that recruitment of macrophages to the kidney 
following injury is not affected by their inability to express FtH.
While macrophage recruitment/proliferation in the injured kidney was not altered by FtH, 
we next sought to determine the polarization profile of macrophages in the FtH+/+ and 
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FtHLysM−/− kidneys after UUO. Intra-cellular staining and flow cytometry revealed that the 
percentage of macrophages (CD45+CD11bhighF4/80low) that expressed TNFα, IL-10 or 
CD206 was not different between FtH+/+ and FtHLysM−/− mice (Supplemental Figure 5). In 
addition, two days following UUO, macrophages were isolated from the kidneys and 
analyzed for the expression of M1 and M2 markers by real-time PCR. While most M1 
(iNOS, TNFα, IL-12) and M2 (MRC, IL-4, Ym1, CX3CR1, IL-10) genes were not 
differentially expressed in the absence of FtH in the macrophages, only arginase (M2) was 
significantly higher in the absence of FtH (Figure 3F). An increase in HO-1 expression was 
also observed in macrophages isolated from the FtHLysM−/− mice kidneys (Figure 3F). No 
significant differences in the expression of receptors (CCR4 and CSF-1R) for chemokines 
(MCP-1 and CSF-1) involved in macrophage recruitment were observed (data not shown).
Proximal tubule FtH deletion exacerbates inflammation following UUO
To elucidate the significance of kidney FtH expression in regulation of inflammation during 
injury, we performed UUO on transgenic mice deficient in FtH expression only in the 
proximal tubules of the kidney (FtHPT−/−) (Figure 4A). We previously demonstrated that 
these mice display increased susceptibility to AKI (cisplatin nephrotoxicity and glycerol-
induced rhabdomyolysis) (22). Two days following UUO, while the number of dendritic 
cells was not different, macrophage accumulation tended to be higher in FtHPT−/− kidneys 
when compared to FtH+/+ kidneys (Figure 4B, Supplemental Figure 6). Specifically, there 
was a significant increase in the inflammatory macrophage subset (Ly6C+CD11C+) with no 
significant difference in the Ly6C+CD11clo macrophage subset (Figure 4B). There was also 
a significant increase in CD62L+ macrophages in the FtHPT−/− kidneys, suggesting that at 
least a proportion of the intra-renal macrophages are derived from the circulation and do not 
arise from in situ proliferation (Figure 4B). In addition, intra-cellular staining and flow 
cytometry revealed that the percentage of macrophages that expressed TNFα, a M1 marker 
was significantly higher in the FtHPT−/− kidneys compared to FtH+/+ kidneys (Supplemental 
Figure 5). Moreover, there was no significant difference in the percentage of IL-10 or 
CD206 expressing M2 macrophages between the FtHPT−/− and FtH+/+ mice (Supplemental 
Figure 5).
Gene expression analysis of macrophages from the injured kidneys revealed predominant 
M1 polarization (TNFα, IL-12), with very low expression of M2 markers (arginase, IL-4, 
Ym1 and CX3CR1) (Figure 4C). In addition, there were no significant differences in the 
expression of receptors for CSF-1 and MCP-1 (data not shown). These results underscore 
the importance of the conducive kidney microenvironment for inflammatory M1 
macrophage polarization.
FtH expression in the kidney regulates macrophage recruitment through CSF-1, MCP-1 
and IL-6
The characterization of inflammatory cells and their phenotype in the absence of FtH in 
different cellular compartments following UUO highlighted the importance of the kidney, 
particularly the proximal tubule epithelial cell, in the regulation of the response to injury. 
Given that kidney-restricted FtH deletion led to a significant increase in macrophage 
infiltration, we determined the expression of chemokines in the kidney that are responsible 
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for their recruitment. While deletion of FtH in the macrophages did not influence chemokine 
expression, absence of FtH in the proximal tubules led to a significant increase in MCP-1 
and CSF-1 (Figure 5). Furthermore, while the pro-inflammatory cytokine, IL-6 was 
significantly higher, the expression of the anti-inflammatory cytokine, IL-10 was lower in 
the kidneys of FtHPT−/− mice when compared to FtH+/+ mice (Figure 5).
FtH expression modulates fibrosis following UUO
In order to determine the effects of FtH deletion in the development of fibrosis, we 
performed reversible UUO on cell-specific FtH deficient mice wherein the ureter is briefly 
clamped for two days followed by clamp removal for five days (Figure 6A). This model 
allows for the determination of cellular responses that occur in the kidney during the 
resolution phase of injury. As evident from Figure 6B and 6C, fibrosis was significantly 
higher in the obstructed kidneys of FtHPT−/− mice. Interestingly, while no significant 
differences were observed in macrophage accumulation (Figure 3), fibrosis was lower in the 
kidneys of FtHLysM−/− mice when compared to kidneys of FtH+/+ mice (Figure 6B). These 
results were further corroborated by expression of fibronectin and alpha-smooth muscle 
actin (Figure 6C). Intriguingly, these effects were also observed in the contralateral kidneys 
(Supplemental Figure 7).
Discussion
Inflammation is an evolutionary defense mechanism in response to injurious stimuli and 
infectious agents with the ultimate goal of minimizing injury and enabling repair (57). 
Hence, it is not surprising that dysregulation of a fundamental mechanism is at the epicenter 
of numerous pathological conditions. In this regard, macrophages have evolved to play a 
major role in orchestrating a delicate balance of opposition to noxious stimuli versus 
assisting in re-establishment of tissue homeostasis (41,42,58).
In this study, we investigated the potential role of FtH in regulating macrophage activation 
and polarization, and the ensuing extent of injury and fibrosis in a model of inflammation 
and fibrosis in the kidney. We confirmed that UUO is associated with a renal influx of 
macrophages in HO-1−/− mice (55), but we show for the first time that these renal 
macrophages exhibit deranged polarization. Further in vitro results revealed that HO-1 
deficient macrophages have increased levels of FtH and is associated with increased 
expression of both M1 and M2 specific markers. The increase in these markers was directly 
attributed to ferritin based on similar results observed in HO-1+/+ macrophages that were 
supplemented with exogenous recombinant FtH or apoferritin and, additionally a decrease in 
expression of the same markers in the absence of FtH. Using cell specific transgenic mice, 
we demonstrate that conditional deletion of FtH in macrophages does not affect influx, 
chemokine expression, or polarization of macrophages. Of note, the LysM promoter used to 
generate myeloid-specific FtH deletion is active in macrophages, dendritic cells and 
granulocytes. However, recent studies indicate that LysM promoter expression is low in 
CD11c+ cells (59). Despite this expression pattern, our studies revealed that there were no 
differences in influx or accumulation of macrophages and dendritic cells in the obstructed 
kidneys of FtHLysM−/− mice. In contrast, specific deletion of FtH in proximal tubule 
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epithelial cells was associated with increased propensity of macrophages to be polarized 
towards a M1 phenotype, a process that correlates with increased injury and ultimately 
fibrosis.
We recognize that while the in vitro studies provided mechanistic insight into the 
polarization of macrophages in a conditioned environment that was predominantly 
dependent on FtH expression, in vivo studies highlight the complex inflammatory 
microenvironment and cellular cross-talk that may not be completely reflected in the in vitro 
state. Furthermore, it is important to recognize that the polarization status may also be 
influenced by the nature of the cytokines in the systemic circulation.
Ferritin is an ancient molecule traditionally thought to be a storage depot for cytoplasmic 
iron. This notion has been recently challenged and emerging data suggest that ferritin is 
responsible for diverse functions that are beyond the scope of merely iron handling. 
Mitochondrial ferritin and localization of FtH in the nucleus have been described and 
underscore the cellular function and regulatory mechanisms that may depend on this 
complex and versatile protein (60–64). Ferritin molecules isolated from vertebrates are 
composed of two types (heavy [H] and light [L] chain) whose proportion depends on the 
iron status of the cell, the tissue, and the organ. The H-chain has ferroxidase activity that is 
essential to prevent cellular damage provoked by reactive oxygen species (65). Increasing 
evidence suggests a role of ferritin in inflammation (66). Elevated levels of ferritin are 
observed in multiple autoimmune disorders and it is also generally accepted that serum 
ferritin is an acute phase reactant (67). While serum ferritin is mainly composed of the iron-
poor L chain, the described receptors are specific for the H-chain (68). Additional evidence 
suggests that FtH has immunomodulatory functions although paradoxical effects have been 
described. For instance, FtH may have immunosuppressive effects via inhibition of antibody 
production by B lymphocytes, suppression of Type IV hypersensitivity to induce anergy and 
stimulation of IL-10 production in lymphocytes (69–71). In addition, lower levels of serum 
ferritin is associated with an increased risk for human acute kidney injury following 
cardiopulmonary bypass surgery (72). In contrast, ferritin has also been shown to exert pro-
inflammatory effects likely via activation of nuclear factor κB (73). Such an effect is 
independent of the iron content of ferritin and, perhaps more importantly, induction of pro-
inflammatory pathways is independent of L or H chain structure (73). Taken together, 
although there is strong evidence to suggest an immunomodulatory role for ferritin, it is 
clear that our understanding of the details of such modulation is in its infancy. Given the fact 
that prolonged or deranged inflammation is a central mediator of numerous clinical 
conditions, further research into this area will greatly enhance our understanding of the 
pathogenesis of such conditions and will provide a platform for novel therapeutic modalities 
and targets to be identified. To this end we were prompted to further delineate the 
function(s) that iron and ferritin may have in inflammation.
Our results indicate that overexpression of FtH in macrophages leads to a state of activation 
that primes these cells to polarize towards the M1 or M2 phenotype depending on the 
cytokines present in their environment. Increased levels of ferritin are likely the result of 
elevated levels of free heme as well as, iron and heme containing proteins such as 
cytochromes that are commonly present during cell injury and death in inflamed tissues. 
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Herein, we demonstrate that conditional deletion of proximal tubule specific FtH, which 
leads to increased levels of free iron in the microenvironment that is ingested by phagocytic 
cells such as macrophages, results in increased M1 macrophage polarization and 
subsequently perpetuates fibrosis, a common determinant of progressive kidney disease 
(Figure 7). Proximal tubular deletion of FtH led to increased levels of several pro-
inflammatory chemokines such as MCP-1, IL-6, CSF-1 and suppression of IL-10 
expression. In addition, a recent study identified IL-6 as a key regulator of UUO-mediated 
fibrosis by induction of collagen expression (74). The pro-inflammatory and pro-fibrotic 
role of myeloid-specific FtH was further validated by lower levels of fibrosis in mice that 
were deficient in macrophage FtH expression.
Interestingly, a recent study demonstrated that while Galectin-3 deletion did not alter 
macrophage recruitment to the kidneys after UUO, adoptive transfer of Galectin-3 deficient 
macrophages led to decreased fibrosis through reduced activation/recruitment of 
myofibroblasts (35). In corroboration with this study, our results also demonstrate that while 
myeloid-specific FtH deletion does not alter macrophage recruitment, it has a significant 
impact on fibrosis. Myeloid FtH deletion also led to marked increase in arginase expression, 
a key enzyme involved in the inhibition of fibrosis (75). The key cellular mediators of 
fibrosis are myofibroblasts, which can be identified by their expression of α-smooth muscle 
actin (SMA). These cells are the principal producers of the extracellular matrix and are often 
found in the tubulointerstitial space following UUO. The origin of these myofibroblasts has 
generated much debate over the past decade and has led to the identification of multiple 
sources for these cells during injury. These include, but not limited to, bone marrow-derived, 
pericyte-derived, and epithelial and endothelial mesenchymal transition (76–78). While the 
principal aim of this study was to identify tubular-macrophage cross-talk in renal fibrosis 
and injury, future studies will need to focus on characterizing the mechanism of 
myofibroblast differentiation in this model. The results from this study not only identify 
macrophage FtH as an important pro-inflammatory molecule but also highlight the 
importance of the crosstalk between the injured epithelial cells and macrophages. Such 
crosstalk is perhaps the ultimate determinant of the extent of injury and the resolution/
outcome of inflammation in which FtH plays a central role.
From a clinical perspective, chronic kidney disease (CKD) and end stage renal disease 
patients commonly demonstrate high levels of serum ferritin (79,80). Circulating ferritin 
may then lead to higher FtH expression in macrophages and as our results demonstrate, high 
ferritin levels are associated with “priming” of macrophages. Although these patients have 
complex and multiple factors that could potentially contribute to changes in macrophage 
polarization, an evaluation of the macrophage phenotype from patients with CKD and 
varying levels of ferritin would be of interest.
Taken together, these results for the first time provide evidence that FtH expression 
regulates macrophage activation and polarization, which are strongly dictated by the 
inflammatory mediators present in the injured proximal tubule epithelial cells and is both 
cell and context dependent (Figure 7). These mediators provide essential communication 
between the injured tissue and activated inflammatory cells that will eventually decide the 
fate of the inflammatory process and fibrosis. Further investigations in this field are required 
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to shed more light on clinical conditions that have chronic inflammation as a common 
denominator with a dedicated focus on targeting FtH expression.
Materials and Methods
Animals
HO-1+/+ and HO-1−/− male mice (10–14 weeks of age) on a mixed C57BL/6 X FVB 
background were used in this study. Macrophages isolated from humanized HO-1 BAC 
transgenic mice (12–14 weeks of age) on a C57BL/6 background were used in this study 
(81). H-ferritin floxed mice and proximal-tubule specific H-ferritin deleted mice that were 
previously described were used in this study and referred to as FtH+/+ and FtHPT−/− (22,82). 
The myeloid-specific H-ferritin deletion mice were generated by breeding FtH+/+ mice with 
LysM-cre transgenic mice and referred to as FtHLysM−/−. All the FtH transgenic mice used 
in this study were predominantly on a C57BL/6 background. Adult male FtHPT−/− mice (8 
weeks of age) were provided acidified water (0.3M ammonium chloride) for 1 week to 
enhance PEPCK promoter activity in the kidney.
Animal model of renal inflammation and fibrosis
UUO surgery was performed as previously described (55). Mice were anesthetized with 
inhalation of isoflurane (1.5%). In the UUO group, the left ureter was exposed through a 
mid-abdominal incision and ligated twice, approximately 1 cm below the renal hilum, using 
a 4-0 silk suture. Sham operation was done in a similar manner, without ureteral ligation. 
Mice were harvested after 2, 5 or 7 days following ligation. Reversible UUO was performed 
by clamping the left ureter with a non-traumatic microvascular clip (5–15 g/mm2, 7 mm 
S&T Vascular Clamp, Fine Science Tools). The clamp was removed two days after 
clamping and animals were allowed to recover for 5 days. At the time of harvest, kidneys 
were analyzed for histopathologic studies, immune cell influx, and gene or protein 
expression analysis.
Fibrosis
Collagen deposition was measured using picrosirius red as previously described (83). 
Briefly, kidneys were cut transversely and fixed in 10% buffered formaldehyde, embedded 
in paraffin and sectioned. The kidney sections were deparaffinized with xylene and then 
rehydrated in water through graded ethanol washes. The sections were incubated in 
picrosirius red for 1 hour followed by two washes in acidified water. The sections were then 
dehydrated, cleared, and mounted in a resinous medium. The area of collagen deposition, 
stained red by picrosirius red staining, was measured by color image analysis software 
(Image-Pro Plus, Media Cybernetics).
Isolation and Enrichment of Renal Leukocytes
Leukocytes were isolated as previously described with minor modifications (84). Mice were 
anesthetized with isoflurane (1.5% in 95% O2) and perfused with 10 ml of ice-cold saline 
through the left ventricle after median thoracotomy to clear the kidney of leukocytes in the 
circulation. The contralateral and obstructed kidneys were explanted, washed with PBS, and 
the capsule was removed. Each kidney was then weighed individually. Kidneys were 
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minced into small pieces and enzymatically digested using 1.67 Wunsch U/ml Liberase DL 
(Roche Diagnostics, Indianapolis, IN) in DMEM medium for 20 minutes at room 
temperature. PEB buffer (PBS, 2mM EDTA, 0.5% BSA) was added to disrupt calcium-
depended cell-cell complexes and to inactivate the Liberase enzyme. Disaggregation was 
completed by mechanical maceration using frosted glass and the homogenate was passed 
through a 70-µm nylon filter (Fisher) to remove undigested and fibrogenous material and 
then centrifuged at 300 g. To remove red blood cells and enrich the renal leukocyte 
population in the total kidney homogenate, the pellet was suspended in NycoPrep 1.077 
gm/ml density gradient solution (Axis-Shield PoC, Oslo, Norway), overlaid with PBS, and 
centrifuged at 1000 × g for 15 minutes. The interface, containing low-density cells, which 
includes macrophages and dendritic cells, was collected and washed in PEB buffer for 
analysis by flow cytometry. For some studies, macrophages were isolated using CD11b 
magnetic microbeads and MACS columns (Miltenyi Biotec) according to the manufacturer’s 
protocol.
Flow Cytometry
Renal leukocytes were washed with staining buffer (PBS, 0.5% BSA, 0.01% Sodium Azide) 
and incubated with anti-mouse CD16/32 for 10 minutes on ice to block nonspecific binding 
of phycoerythrin to FCγ3 receptors. Cells were stained on ice for 30 minutes with 7-
aminoactinomycin D (7-AAD, eBioscience) viability staining solution and flurochrome-
conjugated anti-mouse antibodies for analysis by flow cytometry. Fluorescein isothicyanate-
conjugated CD62L (MEL-14), phycoerythrin-conjugated F4/80 (BM8), allophycocyanin-
conjugated major histocompatibility complex class II (MHC II, M5/114.15.2), eFluor 450-
conjugated Ly-6C (HK1.4), allophycocyanin-eFluor 780-conjugated Ly-6G (Gr-1, 
RB6-8C5), and eFluor 605NC-conjugated CD11b (M1/70) were purchased from 
eBioscience. Brilliant Violet (BV) 785-conjugated CD11c (N418), BV 650-conjugated 
CD45.1 (A20), and BV 650-conjugated CD45.2 (104) were purchased from Biolegend. 
Isotype-matched, fluorescently conjugated antibodies of irrelevant specificity were used as 
controls. Data acquisition was performed on a BD LSR II Flow Cytometer (BD 
Biosciences). Approximately 6 × 105 live (7-AAD−) bone marrow-derived (CD45+) events 
were collected for analysis from each sample. Results were analyzed using FlowJo Software 
(Tree Star Inc, Ashland, OR). The absolute number of live (7-AAD−) bone marrow-derived 
(CD45+) cells per gram of kidney were determined using AccuCheck Counting Beads 
(Invitrogen, Molecular Probes, Camarillo, CA). The absolute number of the renal leukocyte 
subsets was determined by the method described by Moon and colleagues (85).
For intracellular cytokine staining, the cells retrieved from NycoPrep density gradient 
centrifugation were washed once in PBS and then cultured for 4 hours at 37°C and 5% CO2 
in DMEM culture media containing 10% FBS and cell stimulation cocktail (PMA/
ionomycin) plus protein transport inhibitors (Brefeldin A and Monensin). Next the cells 
were washed two times in PBS and then stained with fixable viability dye eFluor 520 for 30 
minutes at 4C, according to the manufacturer’s protocol (eBioscience). The cells were then 
washed twice with staining buffer and cell surface markers (CD45, CD11b, F4/80, Ly6C, 
CD11c) were stained, as described above. The cells were then fixed and permeabilized for 
intracellular cytokine staining according to the manufacturer’s protocol (eBioscience). After 
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staining for intracellular cytokines for 20 minutes at room temperature and 30 minutes on 
ice, the cells were washed twice with staining buffer and then analyzed on an LSRII flow 
cytometer.
Quantification of mRNA Expression
Gene expression analysis was performed as described previously (22). Briefly, total RNA 
was isolated from cells or tissues by TRIzol (Life Technologies), and SYBR Green-based 
real-time PCR was performed on cDNA product generated from total RNA (Qiagen). 
Relative mRNA expression was quantified using the ΔΔCt method and normalized to 
glyceraldehyde 3-phosphate dehydrogenase (GAPDH) mRNA as an internal control. Real-
time primers used in this study are described in Table 1. All the reactions were performed in 
triplicate and specificity was monitored using melting curve analysis.
Isolation and polarization of bone-marrow derived monocytes
BMDMs were isolated and cultured as previously described with minor modifications (38). 
Mouse bone marrow cells were flushed from the femurs of mice and passed through a 40-
µm cell strainer (BD Falcon), and red blood cells were lysed in ACK buffer (0.15 M NH4Cl, 
10 mM KHCO3, 0.1 mM EDTA). Remaining cells were incubated in DMEM medium 
(Corning Cellgro) containing 10% FBS (Atlanta Biologicals), 30 ng/ml MCSF (Miltenyi 
Biotec) and 1% penicillin/streptomycin (Life Technologies). BMDM were cultured for 7 
days and the purity of the culture was determined to be >85% based on analysis of CD11b 
expression. Polarization of cells was performed using 100 U/ml murine recombinant IFN γ 
(Roche) or 20 ng/ml murine recombinant IL-4 (Miltenyi Biotec). For studies involving HO 
by-products or ferritin, pre-treatment was performed 16 hours prior to the addition of 
cytokines. Macrophages were pre-treated with biliverdin (Frontier Scientific), bilirubin 
(Frontier Scientific), deferoxamine (Sigma), CORM (Sigma) or Apoferritin (Sigma). 
Recombinant H ferritin and L ferritin were generously provided by Dr. Arosio. HO-1 
overexpressing macrophages were isolated from humanized HO-1 BAC transgenic mice 
(81). Gene expression analysis was performed at 4 hours and protein expression analysis 
was performed at 24 hours after cytokine treatment.
Western blot analysis
Harvested cells or collected tissues were lysed in RIPA buffer (50 mmol/l Tris/HCl, 1% 
NP-40, 0.25%. deoxycholic acid, 150 mmol/l NaCl, 1 mmol/l EGTA, 1 mmol/l sodium 
orthovanadate, and 1 mmol/l sodium fluoride) with protease inhibitor (Sigma-Aldrich) and 
quantified using BCA protein assay (Thermo Scientific). Total protein (10–15 µg for cells, 
75µg for tissues) was resolved on a 12% Tris-glycine sodium dodecyl sulfate 
polyacrylamide gel electrophoresis and transferred to a polyvinylidene fluoride membrane 
(Millipore). Membranes were blocked with 5% nonfat dry milk in PBST for 1 hour and then 
incubated with a rabbit anti-ferritin H chain antibody (Santa Cruz Biotechnology, 1:5000), a 
rabbit anti-arginase antibody (Santa Cruz Biotechnology; 1:1000), a rabbit anti-iNOS 
antibody (Santa Cruz Biotechnology; 1:1000), a rabbit anti-HO-1 antibody (Enzo 
LifeSciences;1:2000), a rabbit anti-fibronectin (Sigma-Aldrich; 1:10000), a goat anti-L 
Ferritin (Santa Cruz Biotechnology; 1:1000), or a mouse anti-SMA (Sigma-Aldrich; 1:5000) 
followed by a peroxidase-conjugated goat anti-rabbit (or mouse) IgG antibody or donkey 
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anti-goat IgG antibody (Jackson ImmunoResearch Laboratories; 1:10000). Horseradish 
peroxidase activity was detected using enhanced chemiluminescence detection system (GE 
Healthcare). The membrane was stripped and probed with anti-GAPDH antibody (Sigma-
Aldrich; 1:5000) to confirm loading and transfer. Densitometry analysis was performed and 
results were normalized to GAPDH expression and expressed as fold change over controls.
Statistics
Data are presented as mean ± SEM. The unpaired Student's t test was used for comparisons 
between two groups. For comparisons that involved more than two groups, ANOVA and the 
Newman-Keuls test were used for analysis. All results were considered significant at 
P<0.05. All the experiments were performed at least three times.
Study approval
All procedures involving mice were performed in accordance with NIH guidelines for the 
use and care of live animals and were reviewed and approved by the Institutional Animal 
Care and Use Committee (IACUC) of the University of Alabama at Birmingham.
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Figure 1. Heme oxygenase-1 (HO-1) deficiency is associated with increased accumulation of 
immune cells and dysregulated macrophage polarization following unilateral ureteral 
obstruction (UUO)
(A) Diagram of the injury model. (B) Representative flow cytometry histograms of 
obstructed and contralateral kidneys demonstrating the gating scheme and proportions of 
immune cell populations. (C) Quantification of the number of cells in the obstructed kidneys 
of HO-1+/+ and HO-1−/− mice two days following UUO. Data are represented as number of 
cells per gram kidney. n=5–8 per group; p<0.05 vs HO-1+/+. Each experiment was 
performed at least three independent times. (D) Gene expression analysis of polarization 
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markers (M1: iNOS, TNFα; M2: Arginase, Mannose receptor) on macrophages isolated 
from obstructed kidneys of HO-1+/+ and HO-1−/− mice at the indicated times following 
UUO. Data were normalized to sham controls. n=5–8 per group; experiments were repeated 
three independent times; p<0.05 vs HO-1+/+.
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Figure 2. H-Ferritin mediates macrophage polarization
(A) Diagram demonstrates macrophage polarization pathways. (B) HO-1+/+ and HO-1−/− 
bone marrow-derived monocytes (BMDM) were cultured in vitro in the presence of M-CSF 
and stimulated with IFNγ (100 U/ml) or IL-4 (20 ng/ml) for 24 h to induce M1 or M2 
polarization respectively. Whole cell lysates were analyzed for the expression of iNOS 
(M1), arginase (M2) and FtH by western blot analysis. Membranes were probed for GAPDH 
to demonstrate equal loading. (C) HO-1−/− BMDM were pre-treated with vehicle (water) or 
deferoxamine (DFO; 150 µM) for 16 h prior to stimulation with IFNγ or IL-4. Western 
analysis was performed for the expression of iNOS, arginase and FtH. (D) HO-1+/+ BMDM 
were pretreated with apoferritin (0.1mg/ml), stimulated with IFNγ or IL-4 and analyzed for 
the expression of iNOS, arginase, FtH and HO-1 by western blot analysis. (E) HO-1+/+ 
BMDM were pre-treated with H-ferritin or mutant-H-Ferritin, stimulated with IFNγ or IL-4 
and analyzed for the expression of iNOS, arginase, FtH, HO-1 and GAPDH by western blot 
analysis. All experiments were repeated at least three independent times.
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Figure 3. Myeloid-specific FtH deletion does not influence inflammation and macrophage 
polarization in vivo
(A) FtH mRNA expression in the macrophages of FtH+/+ and FtHLysM−/− mice was 
analyzed by real-time PCR. Results are expressed as FtH gene expression normalized to 
GAPDH. Values are presented as mean ± SEM; *p < 0.05 vs FtH+/+. n=3/group. (B) 
Macrophages isolated from FtH+/+ and FtHLysM−/− mice were analyzed for FtH protein 
expression. (C) BMDM from FtH+/+ and FtHLysM−/− mice were treated with vehicle (M0), 
IFNγ (M1) or IL-4 (M2) and analyzed for the expression of iNOS, arginase, FtH, FtL and 
HO-1 by western blot analysis. Membranes were stripped and re-probed for GAPDH to 
demonstrate equal loading. (D) Diagram representation of the site-specific expression of FtH 
in FtHLysM−/− mice. (E) Quantification of the number of cells in the obstructed kidneys of 
FtH+/+ and FtHLysM−/− mice two days following UUO. Data are represented as number of 
cells per gram kidney. n=4–6 per group; p<0.05 vs FtH+/+. Experiments were performed 
three independent times. (F) Gene expression analysis of polarization markers (M1: iNOS, 
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TNFα, IL-12; M2: Arginase, Mannose receptor, IL-4, Ym1, CX3CR1, IL-10) and HO-1 on 
macrophages isolated from obstructed kidneys of FtH+/+ and FtHLysM−/− mice following 
UUO. Experiments were performed at least three times and gene expression data were 
normalized to GAPDH, analyzed and represented as mean ± SEM; n=5–8 per group; p<0.05 
vs FtH+/+.
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Figure 4. Proximal tubule specific FtH deletion leads to increased macrophage infiltration and 
altered polarization profile following UUO
(A) Diagram representation of FtHPT−/− mice. (B) Two days post UUO, obstructed kidneys 
of FtH+/+ and FtHPT−/− mice were analyzed for the presence of immune cells by flow 
cytometry. Data are represented as number of cells per gram kidney. n=4–6 per group; p < 
0.05 vs FtH+/+. (C) Macrophages isolated from the obstructed kidneys were analyzed for the 
expression of, M1 (iNOS, TNFα, IL-12), M2 genes (Arginase, Mannose receptor, IL-4, Ym1, 
CX3CR1, IL-10) and HO-1. Experiments were performed at least three independent times 
and gene expression data were normalized to GAPDH, analyzed and represented as mean ± 
SEM; n=5–8 per group; p<0.05 vs FtH+/+.
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Figure 5. Elucidation of myeloid-specific and proximal tubule-specific H Ferritin deletion on 
inflammatory chemokines during UUO injury
Two days following UUO, obstructed kidneys of FtH+/+, FtHLysM−/− and FtHPT−/− mice 
were analyzed for the expression of chemokines (CSF-1; colony stimulating factor and 
MCP-1; monocyte chemoattractant protein), inflammatory (IL-6) and anti-inflammatory 
(IL-10) cytokines and HO-1 and FtH by Real-time PCR analysis. Each experiment was 
performed at least three independent times. Results were normalized to GAPDH and 
presented as mean ± SEM; n-4–6 per group. *p < 0.05 vs FtH+/+ mice.
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Figure 6. Elucidation of myeloid-specific and proximal tubule-specific H Ferritin deletion on 
fibrosis during UUO injury
(A) Illustration of experimental design. Two days following clamping of the ureter, the 
clamp is removed and animals were allowed to recover for five days. (B) Picrosirius staining 
was performed on the obstructed kidney sections to determine fibrosis following injury. 
Representative images of the stained kidney sections are shown in the upper panel (scale bar 
– 400 µm) and middle panel (scale bar – 100 µm). Lower panel: graphical representation of 
the collagen deposition in the kidneys. *p<0.05 vs FtH+/+ mice; n=5–6 per group. 
Experiment was repeated at least three independent times. (C) Whole kidney lysates from 
the obstructed kidneys of FtH+/+, FtHLysM−/− and FtHPT−/− mice were analyzed for changes 
in fibrosis (fibronectin and α-smooth muscle actin) by western blot analysis. Expression of 
the indicated proteins in the kidneys was analyzed by densitometry, normalized to GAPDH 
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and expressed as mean ± SEM; *p < 0.05 vs FtH+/+ mice. **p<0.05 vs FtHPT−/− mice. 
Experiment was performed using triplicates at least two independent times.
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Figure 7. Model depicting the cell-specific effects of FtH in the regulation of inflammation and 
fibrosis
The absence of FtH in the proximal tubule leads to aggravated injury that comprises of 
increased generation of chemokines (MCP-1 and CSF-1) and cytokines such as IL-6, 
followed by an increase in macrophage recruitment and polarization towards the pro-
inflammatory phenotype, resulting in increased fibrosis. Increased expression of α-smooth 
muscle actin may also indicate alternate pathways, including activation of (myo)fibroblasts 
by the injured epithelium and IL-6. Myeloid FtH deficiency leads to reduced fibrosis 
following UUO, possibly through mechanisms involving arginase and (myo)fibroblast 
recruitment and activation.
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Table 1
Primers for genotyping and Real-time PCR analysis
Assay Gene Primer sequence (5’-3’)
Genotyping
H-ferritin flox For ccatcaaccgccagatcaac
H-ferritin flox Rev cgccatactccaggaggaac
Cre Fwd gccaggcgttttctgagcatac
Cre Rev caccattgcccctgtttcactatc
Real-time PCR
HO-1 Fwd ggtgatggcttccttgtacc
HO-1 Rev agtgaggcccataccagaag
GAPDH Fwd atcatccctgcatccact
GAPDH Rev atccacgacggacacatt
L-Ferritin Fwd cgtctcctcgagtttcagaac
L-Ferritin Rev ctcctgggttttaccccattc
H-Ferritin Fwd ccatcaaccgccagatcaac
H-Ferritin Rev gaaacatcatctcggtcaaa
Arginase Fwd ctccaagccaaagtccttagag
Arginase Rev aggagctgtcattagggacatc
iNOS Fwd ccaagccctcacctacttcc
iNOS Rev ctctgagggctgacacaagg
TNFα Fwd acggcatggatctcaaagac
TNFα Rev agatagcaaatcggctgacg
MRC Fwd cctgtgctcgagaggatatg
MRC Rev gcagtctgcataccacttgt
Ym1 Fwd ttcttgtcacaggtctgg
Ym1 Rev tccttagcccaactggtatag
IL-4 Fwd gagactctttcgggcttttc
IL-4 Rev tgatgctctttaggctttcca
CX3CR1 Fwd tcccttcccatctgctcag
CX3CR1 Rev acaatgtcgcccaaataacagg
CSF-1 Fwd cgggcatcatcctagtcttgctgactgt
CSF-1 Rev atagtggcagtatgtggggggcatcctc
IL-6 Fwd ctgcaagagacttccatccag
IL-6 Rev agtggtatagacaggtctgttgg
IL-10 Fwd gctcttactgactggcatgag
IL-10 Rev cgcagctctaggagcatgtg
MCP-1 Fwd actcacctgctgctactcat
MCP-1 Rev ctacagcttctttgggaca
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